We are working to provide relief for millions of people with debilitating diseases.

Using worms. 

Worms have tremendous therapeutic potential.

Decades of pre-clinical evidence has shown that worms can treat many disease, including the following:

  • EOSINOPHILIC ESOPHAGITIS

  • ASTHMA

  • ULCERATIVE COLITIS

  • CROHNS DISEASE

  • MULTIPLE SCLEROSIS

  • LUPUS

  • RHEUMATOID ARTHRITIS

Millions of patients continue to suffer from these debilitating diseases, which have multi-billion dollar market potential. Despite this, not a single worm-derived molecule has been taken into clinic.

HOLOCLARA is the first to mine worm-derived small molecules and develop patent-protected, chemistry-driven programs for FDA approval, with our first molecule heading to clinic in 2024.

Our Mission